Biotech

All Articles

ProKidney halts phase 3 test not needed for tissue treatment permission

.ProKidney has actually ceased among a pair of phase 3 tests for its tissue therapy for kidney illne...

Vaxcyte rises on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte introduced what analysts named "remarkable" period 1/2 information for its 31-valent pneumo...

Recursion's brain disease test presents little documentation of efficacy

.Recursion has discovered by means of a very early exam of its tech-enabled approach to drug explora...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Phone it a scenario of excellent chemical make up: Acepodia, a biotech based upon Nobel Champion sc...

Praxis epilepsy drug minimizes seizures in period 2 trial

.Practice Precision Medicines has actually scored one more midphase gain in epilepsy this year, alon...

Three execs resign as Dyne articles mixed records for DMD applicant

.After getting away a medical hold a number of years back, Dyne Rehab has actually revealed brand-ne...

Arrowhead fires off phase 3 records in rare metabolic condition before market clash with Ionis

.Arrowhead Pharmaceuticals has shown its own hand before a potential face-off with Ionis, posting pe...

Pfizer, Valneva present lyme illness chance successful for 2nd enhancer

.Pfizer as well as Valneva might possess regarding two more years to wait prior to they help make th...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a chat along with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle Benz...

New data demonstrate how Bayer's asundexian failed to avoid movements

.Bayer put on hold the stage 3 test for its own element XIa inhibitor asundexian behind time in 2015...